Cover: Designing a Capitation Payment Plan for Medicare End Stage Renal Disease Services

Designing a Capitation Payment Plan for Medicare End Stage Renal Disease Services

Published 1994

by Donna O. Farley, Joel Kallich, Grace M. Carter, Thomas W. Lucas, Karen Spritzer


Download eBook for Free

FormatFile SizeNotes
PDF file 6.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 Format Price
Add to Cart Paperback139 pages $35.00

This reports presents findings from a study of design options and payment methods for a capitation payment plan for the Medicare End Stage Renal Disease (ESRD) Program. The study contributes to payment policy development by evaluating capitation as an alternative payment method to control Medicare costs while maintaining access and quality of care for ESRD patients. A capitation payment method has been developed that combines monthly capitation payments for dialysis and functioning graft patients with one-time payments for kidney transplant and graft failure events.

Research conducted by

This report is part of the RAND monograph report series. The monograph/report was a product of RAND from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.